My watch list
my.bionity.com  
Login  
Molenstraat 110
5342 CC Oss
Netherlands
Tel.
+31412661222
Fax
+31412662617

Company Portrait

Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include immunology and specific areas of oncology. Organon products are distributed in over 100 countries worldwide, of which more than 50 have an Organon subsidiary. Organon is the human healthcare business unit of Akzo Nobel.

Focus: Manufacturer

Industrial Sectors

  • Pharma

Contact / Request information

Contact the company and request further information free of charge:

Watchlist

This is where you can add this company to your personal favourites

More about N.V. Organon
  • News

    Akzo Nobel completes OBS sale

    Akzo Nobel N.V. has completed the sale of Organon BioSciences N.V. to Schering-Plough Corporation for EUR 11 billion. Confirmation of the completion of the transaction comes after Schering-Plough received all the necessary approvals, including clearance from the U.S. Federal Trade Commissio ... more

    Organon signs an exclusive, worldwide licence agreement on advanced antithrombotic compounds with Endotis Pharma

    Organon, the human healthcare business unit of Akzo Nobel, announced that it has signed an exclusive, worldwide license agreement with Endotis Pharma concerning the development and commercialization of several antithrombotic compounds. Endotis is a specialty pharma company dedicated to the ... more

    European expert consortium combines forces to develop a novel pandemic influenza vaccine

    A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination. The four-year project has been awarded a grant of EUR3.5 million from the European Union to help fund t ... more

  • Companies

    N.V. Organon

    Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core the ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE